Has Jill Smith, OD received payments from drug or device companies?

Yes. Drug and device makers reported $2,218 in general payments to Jill Smith, OD across 89 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jill Smith, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jill Smith, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jill Smith, OD

Optometrist · Kansas City, MONPI 1760454730

Payments from drug & device makers

$2,218in general payments, 2019–2025

Across 89 payments — averaging $24.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson Vision Care, Inc.$1K
Alcon$402
Bausch & Lomb Americas Inc.$160
Coopervision Inc.$89
Tarsus Pharmaceuticals, Inc.$67
Glaukos Corporation$53
plus $85 from 4 others

What the payments were for

Food & beverage$2,19999%
Gifts$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson Vision Care, Inc.	43	$1,362
Alcon	25	$402
Bausch & Lomb Americas Inc.	9	$160
Coopervision Inc.	4	$89
Tarsus Pharmaceuticals, Inc.	3	$67
Glaukos Corporation	1	$53
Sun Pharmaceutical Industries Inc.	1	$36
Carl Zeiss Meditec AG	1	$19
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$17
Mallinckrodt Hospital Products Inc.	1	$13

How this compares

$2,218 in reported general payments places this provider in the 75th percentile of 1,030 optometrist providers in Missouri.

See all optometrist providers in Missouri →

Medicare billing

Part B allowed, 2024

$59,966

Medicare patients

378

Services billed

683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Latanoprost	90	$1,243
Prednisolone Acetate	35	$1,239
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	46	$874
Timolol Maleate	17	$223

Paid to pharmacies, not to this prescriber.

Other optometrist in Kansas City

Anthony VerachtertKansas City$959K
Geoffrey PowellKansas City$154K
Crystal RemingtonKansas City$101K
Michael MooreKansas City$18K
Kristen YatesKansas City$12K
Lynn GastonKansas City$11K
Kelsey KleinsasserKansas City$10K
Kelli SmithKansas City$7K
Joseph CastellanoSaint Louis$369K
Richard WilsonRaytown$355K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →